Skip to main content
. 2020 Mar 24;24:102. doi: 10.1186/s13054-020-2778-x

Fig. 2.

Fig. 2

The hypoinflammatory and hyperinflammatory subphenotypes of ARDS are associated with different biomarkers and outcomes. These two distinct subphenotypes have been identified by Calfee et al. in multiple previous ARDS clinical trial cohorts [27, 29, 40, 41]. IL interleukin, bicarb bicarbonate, TNFr1 tumor necrosis factor receptor 1